Nishant Pant describes a trade set-up in the SPDR Gold Shares.
Goldman warns these defense stocks could take a hit from Trump spending cuts
The firm said defense valuations are already high and forecasts the U.S. defense budget will soon flatten out and then decline.
Morgan Stanley found a new autonomous driving pure play, gives it 25% upside
WeRide will benefit from its early-mover advantage in self-driving vehicles, per Morgan Stanley.
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, Meta, Uber, Netflix, Apollo, Datadog & more
Here are the biggest calls on Wall Street on Tuesday.
UBS upgrades this HVAC stock, says it can benefit from AI push
Analyst Joshua Chan upgraded shares to buy from neutral.
Evercore ISI upgrades BioNTech, says ‘chaos’ of RFK Jr.’s nomination presents buying opportunity
Now may be the time for investors to buy shares of BioNTech, according to Evercore ISI.
Jefferies says buy this pharmaceutical play, sees more than 100% upside from here
This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.
Goldman Sachs sees this dividend play returning 20% annualized over next four years
Investors may like AT&T for its juicy dividend, but it also has “significant upside” ahead, according to Goldman Sachs.
There’s trouble brewing in the chip sector outside of Nvidia, according to the charts
A look at the failing charts of Applied Materials and Lam Research.
Dental supply stock rallies on theory RFK’s anti-fluoride stance will prompt more dentist visits
Henry Schein shares tracked for their second best day of 2024 on Monday.